ClinConnect ClinConnect Logo
Search / Trial NCT05286151

Network Connectivity and Temporal Processing in Adolescents Who Stutter

Launched by UNIVERSITY OF MICHIGAN · Mar 9, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Rhythm Temporal Processing Healthy Children Speech Disorders Timing

ClinConnect Summary

This clinical trial is studying how children who stutter compare to those who do not in tasks related to rhythm, such as understanding and making music. The goal is to find out if the way these children perceive and produce rhythm is linked to how their brains work, which could help us understand stuttering better.

The trial is looking for children aged 3 to 12 years who speak English. Eligible participants who stutter must have a current or past diagnosis of stuttering, while those who do not stutter should have no history of stuttering in themselves or their families. Participants will take part in activities that assess their rhythm skills, and researchers will observe their brain activity during these tasks. It's important to note that children with certain medical conditions or disabilities, like significant hearing loss or neurological issues, cannot participate. This is a great opportunity for families interested in contributing to research that could help improve understanding and treatment of stuttering.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria Children who stutter:
  • English as primary language
  • Current or past stuttering diagnosis
  • Inclusion Criteria Children who do not stutter:
  • English as primary language
  • Exclusion Criteria Children who stutter:
  • Diagnosed/under treatment for any neurological or psychiatric conditions
  • Head trauma with loss of consciousness
  • Major medical illness
  • Hearing loss- Language/motor delay (below -2 standard deviations on standardized assessments)
  • Face, motor, or reflex abnormalities
  • Exclusion Criteria Children who do not stutter:
  • Personal or family history of stuttering
  • Diagnosed/under treatment for any neurological or psychiatric conditions
  • Head trauma with loss of consciousness
  • Major medical illness
  • Hearing loss
  • Language/motor delay (below -2 standard deviations on standardized assessments
  • Face, motor, or reflex abnormalities

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Ann Arbor, Michigan, United States

Ann Arbor, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Soo-Eun Chang, PhD

Principal Investigator

University of Michigan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials